•A securities class action lawsuit was filed against Veritone (VERI) on behalf of investors who acquired securities between October 2025 and April 2026.
•The lawsuit follows the company's admission that previously filed financial statements should no longer be relied upon due to improper revenue accounting.
•A jury in the U.S. District Court for the District of Massachusetts delivered a verdict in favor of Abiomed in a patent dispute against Getinge's subsidiary Maquet.
•The jury found that Abiomed did not infringe any Maquet patents relating to intravascular heart pump technology.
•The Georgia Public Service Commission approved a plan to lower overall rates and deliver approximately $50 in annual savings for typical residential customers.
•Tevogen Bio Holdings announced progress on strategic acquisition initiatives that could realize approximately $100 million in combined annual revenue if completed.